Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein Elevated in Blood Predicts Post-Concussion Symptom Severity in Professional Athletes

  • Entrepreneurs to venture capitalists: Don?t be a Scrooge

  • Pain in a dish: Researchers turn skin cells into pain sensing neurons

  • Better assessment of decision-making capacity

  • Problem gambling, personality disorders often go hand in hand

  • Gene discovered that reduces risk of stroke

  • Homosexuality may help us bond, experts say

  • Asymptomatic atherosclerosis linked to cognitive impairment

  • How environment contributes to several human diseases

  • Alzheimer's in a dish model converts skin cells to induced neurons expressing amyloid-beta and tau

  •